Monoclonal antibodies in immune and inflammatory diseases.
The era of monoclonal antibody-based therapeutics has arrived. Monoclonal antibodies of high quality targeting almost any antigen can now be engineered and manufactured in large quantities. In the clinic, monoclonal antibodies are proving to be safe and effective for the treatment of a wide range of...
Main Authors: | Andreakos, E, Taylor, P, Feldmann, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2002
|
Similar Items
-
T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases.
by: Monaco, C, et al.
Published: (2004) -
The role of monoclonal antibody affinity in mediating protection against autoimmune inflammatory diseases
by: Dallenbach, K, et al.
Published: (2011) -
INTERACTION OF MONOCLONAL-ANTIBODIES WITH THE IMMUNE-SYSTEM
by: Clark, M, et al.
Published: (1986) -
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.
by: Isaacs, J, et al.
Published: (1997) -
Antibodies for inflammatory disease : cytokines.
by: Taylor, P
Published: (2000)